However, in contrast to e.g. cutaneous melanoma, downregulation of MHC class I have shown to correlate to longer survival for patients with uveal melanoma (42, 43, 45), indicating a possibility to introduce non-MHC-restricted treatment strategies. The gene discussed is HLA-C; the disease is uveal melanoma.